Effects of protein kinase C inhibitors in in situ and isolated ischemic rabbit myocardium

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 12, 1997, Pages 3345-3356

  Lasley, Robert D ^a,b   Noble, Mark A ^a   Mentzer Jr , Robert M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Bisindolylmaleimide; Chelerythrine; Microdialysis; Myocardial infarct size; Post ischemic function; Protein kinase C

Indexed keywords

BISINDOLYLMALEIMIDE; CHELERYTHRINE; DIOCTANOIN; PROTEIN KINASE C INHIBITOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY;

ANIMALIA; CANIS FAMILIARIS; ORYCTOLAGUS CUNICULUS;

EID: 0031458142     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0559     Document Type: Article

References (47)

1. BAXTER GF, GOMA FM, YELLON DM, 1995. Involvement of protein kinase C in delayed cytoprotection following sublethal ischaemia in rabbit myocardium. Br J Pharmacol 115: 222-224.
2. BIRNBAUM Y, HALE SL, KLONER RA, 1997. Differences in reperfusion length following 30 minutes of ischemia in the rabbit influence infarct size, as measured by triphenyltetrazolium chloride staining. J Mol Cell Cardiol 29: 657-666.
3. BREW EC, MITCHELL MB, REHRING TF, GAMBONI-ROBERTSON F, MCINTYRE RC, HARKEN AH, BANERJEE A, 1995. Role of bradykinin in cardiac functional protection after global ischemia-reperfusion in rat heart. Am J Physiol 269: H1370-H1378.
4. BUDWORTH J, GESCHER A, 1995. Differential inhibition of cytosolic and membrane-derived protein kinase C activity by staurosporine and other kinase inhibitors. FEBS Lett 362: 139-142.
5. BUGGE E, YTREHUS K, 1995. Ischaemic preconditioning is protein kinase C dependent but not through stimulation of α adrenergic or adenosine receptors in the isolated rat heart. Cardiovascular Res 29: 401-406.
6. 2+ in adult rat cardiac myocytes. Circ Res 66: 1143-1155.
7. FORD DA, GROSS RW, 1989. Differential accumulation of diacyl and plasmalogenic diglycerides during myocardial ischemia. Circ Res 64: 173-177.
8. HARA H, ONODERA H, YOSHIDOMI M, MATSUDA Y, KOGURE K, 1990. Staurosporine, a novel protein kinase C inhibitor, prevents postischemic neuronal damage in the gerbil and rat. J Cereb Blood Flow Metab 10: 646-653.
9. HERBERT JM, AUGEREAU JM, GLEYE J, MAFFRAND JP, 1990. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Comm 172: 993-999.
10. Hu B, ALTSCHULD RA, HOHL CM, 1991. Phorbol esters anbd cyclic AMP activate AMP deaminase in adult rat cardiac myocytes. Arch Biochem Biophys 291: 100-106.
11. 1B-adrenoceptors, pertussis toxin-sensitive G proteins, and protein kinase C. Circulation 92: 2259-2265.
12. JACOBSON PB, KUCHERA SL, METZ A, SCHACHTELE C, IMRE K, SCHRIER DJ, 1995. Anti-inflammatory properties of Go 6850 - a selective inhibitor of protein kinase C. J Phamarcol Exp Ther 275: 995-1002.
13. JORDAN NJ, WATSON ML, YOSHIMURA T, WESTWICK J, 1996. Differential effects of protein kinase C inhibitors on chemokine production in human synovial flbroblasts. Br J Pharmacol 117: 1245-1253.
14. KARMAZYN M, WATSON JE, MOFFAT MP, 1990. Mechanisms for cardiac depression induced by phorbol myristate acetate in working rat hearts. Br J Pharmacol 100: 826-830.
15. KITAKAZE M, NODE K, MINAMINO T, KOMAMURA K, FUNAYA H, SHINOZAKI Y, CHUJO M, MORI H, INOUE M, HORI M, KAMADA T, 1996. Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5′-nucleotidase. Circulation 93: 781-791.
16. + exchange inhibition in ischemic, reperfused porcine hearts. Circulation 92: 912-917.
17. LASLEY RD, NOBLE MA, PAULSEN KL, MENTZER RM JR, 1994. Adenosine attenuates phorbol ester-induced negative inotropic and vasoconstrictive effects in rat hearts. Am J Physiol 266: H2159-H2166.
18. 1 analogue and ischemic preconditioning in isolated rabbit hearts. Ann Thorac Surg 60: 1698-1703.
19. LIU Y, COHEN MV, DOWNEY JM, 1994a. Chelerythrine, a highly selective protein kinase C inhibitor, blocks the anti-infarct effect of ischemic preconditioning in rabbit hearts. Cardiovascular Drugs Ther 8: 881-882.
20. LIU Y, YTREHUS K, DOWNEY JM, 1994b. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 26: 661-668.
21. MAIESE K, BOCCONE L, 1995. Neuroprotection by peptide growth factors against anoxia and nitric oxide toxicity requires modulation of protein kinase C. J Cereb Blood Flow Metab 15: 440-449.
22. MAIESE K, BONIECE I, SKURAT K, WAGNER JA, 1993. Protein kinases modulate the sensitivity of hippocampal neurons to nitric oxide toxicity and anoxia. J Neurosci Res 36: 77-87.
23. MARBER MS, MESTRIL R, CHI S-H, SAYEN MR, YELLON DM, DILLMAN WH, 1996. Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J Clin Invest 95: 1446-1456.
24. MEGHJI P, MIDDLETON KM, NEWBY AC, 1988. Absolute rates of adenosine formation during ischaemia in rat and pigeon hearts. Biochem J 249: 695-703.
25. MITCHELL MB, MENG X, Ao L, BROWN JM, HARKEN AH, BANERJEE A, 1995. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res 76: 73-81.
26. MUROHARA T, BUERKE M, MARGIOTTA J, et al. 1995. Myocardial and endothelial protection by TMS in ischemia-reperfusion. Am J Physiol 269: H504-H514.
27. 2 and C in myocardial ischemic reperfusion injury. Am J Physiol 260: H877-H883.
28. PRZYKLENK K, SUSSMAN MA, SIMKHOVICH BZ, KLONER RA, 1995. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model. Circulation 92: 1546-1557.
29. RAMASAMY R, LIU H, ANDERSON S, LUNDMARK J, SCHAEFER S, 1995. Ischemic preconditioning stimulates sodium and proton transport in isolated rat hearts. J Clin Invest 96: 1464-1472.
30. RASMUSSEN H, TAKUWA Y, PARK S, 1987. Protein kinase C in the regulation of smooth muscle contraction. FASEB J 1: 177-185.
31. SANDHU R, DIAZ RJ, WILSON GJ, 1993. Comparison of ischaemic preconditioning in blood perfused and buffer perfused isolated heart models. Cardiovasc Res 27: 602-607.
32. SCALIA R, MUROHARA T, DELYANI JA, NOSSULI TO, LEFER AM, 1996. Myocardial protection by N,N,N-trimethylsphingosine in ischemia reperfusion injury is mediated by inhibition of P-selectin. J Leuk Biol 59: 317-324.
33. SPEECHLY-DICK ME, MOCANU MM, YELLON DM, 1994. Protein kinase C. Its role in ischemic preconditioning in the rat. Circ Res 75: 586-590.
34. 1-receptor-independent activation of protein kinase C in acute myocardial ischemia. Mechanisms for sensitization of the adenylyl cyclase system. Circ Res 70: 1304-1312.
35. SUGDEN PH, BOGOYEVITCH MA, 1995. Intracellular signalling through protein kinases in the heart. Cardiovascular Res 30: 478-492.
36. TANG H, SHIRAI H, INAGAMI T, 1995. Inhibition of protein kinase C prevents rapid desensitization of type 1B angiotensin II receptor. Circ Res 77: 239-248.
37. THAKKAR JK, JANERO DR, YARWOOD C, SHARIF HM, 1993. Modulation of mammalian cardiac AMP deaminase by protein kinase C-mediated phosphorylation. Biochem J 291: 523-527.
38. TOSAKI A, MAULIK N, ENGELMAN DT, ENGELMAN RM, DAS DK, 1996. The role of protein kinase C in ischemic/ reperfused preconditioned isolated rat hearts. J Cardiovasc Pharmacol 28: 723-731.
39. TOULLEC D, PIANETTI P, COSTE H, BELLEVERGUE P, GRANDPERRET T, AJAKANE M, BAUDET V, BOISSIN P, BOURSIER E, LORIOLLE F, DUHAMEL L, CHARON D, KIRILOVSKY J, 1991. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266: 15771-15781.
40. 1-adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res 75: 576-585.
41. VAHLHAUS C, SCHULZ R, POST H, ONALLAH R, HEUSCH G, 1996. No prevention of ischemic preconditioning by the protein kinase C inhibitor staurosporine in swine. Circ Res 79: 407-414.
42. VAN WYLEN DGL, WILLIS J, SODHI J, WEISS RJ, LASLEY RD, MENTZER RM, 1990. Cardiac microdialysis to estimate interstitial adenosine and coronary blood flow. Am J Physiol 258: H1642-H1649.
43. VOGT AM, HTUN P, ARRAS M, PODZUWEIT T, SCHAPER W, 1996. Intramyocardial infusion of tool drugs for the study of molecular mechanisms in ischemic preconditioning. Basic Res Cardiol 91: 389-400.
44. WILKINSON SE, HALLAM TJ, 1994. Protein kinase C: is its pivotal role in cellular activation over-stated? Trends Pharmacol Sci 15: 53-57.
45. WILKINSON SE, PARKER PJ, NIXON JS, 1993. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J 294: 335-337.
46. YOSHIDA K, HIRATA T, AKITA Y, MIZUKAMI Y, YAMAGUCHI K, SORIMACHI Y, ISHIHARA T, KAWASHIAMA S, 1996. Translocation of protein kinase C-α, δ and ε isoforms in ischemic rat heart. Biochim Biophys Acta 1317: 36-44.
47. YTREHUS K, LIU Y, DOWNEY JM, 1994. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 266: H1145-H1152.